ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $3.12M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$1.43M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$985K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$698K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$28.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$25.3K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
LPL Financial
San Diego,
California
| $1.35M | +$1.43M | +49,538 | New |
|
|
VKH
2
Virtu KCG Holdings
New York
| $978K | +$985K | +34,235 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $693K | +$698K | +24,256 | New |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $29K | +$28.8K | +1,000 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $25K | +$25.3K | +878 | New |
|
|
BBPWM
6
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $11K | +$11.5K | +400 | New |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $7K | +$7.19K | +250 | New |
|
|
AIG
8
American International Group
New York
| $6K | +$5.75K | +200 | New |
|
|
MFS
9
MSI Financial Services
Springfield,
Massachusetts
| $5K | +$5.47K | +190 | New |
|
10
Creative Planning
Overland Park,
Kansas
| $3K | +$2.88K | +100 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $3K | +$2.88K | +100 | New |
|
CNCR Hedge Fund Activity: Q4 2015 in Review
11 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) for Q4 2015, worth a combined $3.12M.
Buyers outnumbered sellers: 11 funds opened new CNCR positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was LPL Financial, opening a new position worth an estimated $1.43M.
- 11 institutional investors held ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $3.12M of ETF Series Solutions Trust Range Cancer Therapeutics ETF stock for Q4 2015.
- 11 funds opened new ETF Series Solutions Trust Range Cancer Therapeutics ETF positions in Q4 2015 and 0 closed out, a net change of +11 holders.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF buyer in Q4 2015 was LPL Financial, an estimated $1.43M added.
Based on aggregated 13F filings for Q4 2015.